SAVE THE DATE FOR OUR 2019 ANNUAL PUBLIC FORUM ON SEPTEMBER 5, 2019 IN WASHINGTON, DC!

Advancing the health and safety of patients through innovation.

Learn More >

MDIC is the only public-private partnership (PPP) developed to work with government and industry stakeholders in an effort to advance solutions that promote patient access to innovative medical technologies.

Latest News:

MDIC Releases RFI on Creating Human Cell Lines

MDIC released a Request for Information (RFI) on March 30, 2019. We are requesting technical information about available and possible approaches for creating a set of human cell lines that include all–or subsets of– specific variants. The variants were drawn from a larger list developed by the MDIC SRS working group and include clinically actionable […]

MDIC to Release RFI on Creating Human Cell Lines

MDIC will release a Request for Information (RFI) on March 30, 2019. We are requesting technical information about available and possible approaches for creating a set of human cell lines that include all–or subsets of– specific variants. The variants were drawn from a larger list developed by the MDIC SRS working group and include clinically […]

MDIC Releases Catalog of Known SRS Products for NGS-based Oncology Tests

On March 6, 2019, MDIC released a Landscape Analysis report compiling all the currently available somatic variant reference samples for next-generation sequencing-based tests. This report, researched and assembled by MDIC’s Somatic Reference Samples Landscape Analysis working group, is a catalog of known SRS products for NGS-based oncology tests compiled in one resource, according to the […]

Core Initiatives: